Dr. Kensei Tsuzaka Appointed Chief Advisor for Regenerative Medicine at Tokyo Relife Clinic
Tokyo Relife Clinic appoints Dr. Kensei Tsuzaka as Chief Advisor for Regenerative Medicine, strengthening its system by integrating internal medicine and immunology expertise.
📋 Article Processing Timeline
- 📰 Published: April 1, 2026 at 20:00
Tokyo Relife General Incorporated Association (Location: Ginza, Chuo-ku, Tokyo; CEO: Yoshiaki Furuyama) is pleased to announce that Dr. Kensei Tsuzaka has been appointed as Chief Advisor for Regenerative Medicine at Tokyo Relife Clinic, effective April 1, 2026. This appointment aims to advance the field of regenerative medicine and further strengthen the clinic's medical system.
1. Significance of the Appointment
After graduating from Keio University School of Medicine, Dr. Tsuzaka obtained his Ph.D. from the same university's graduate school. He engaged in basic medical research at the Oklahoma Medical Research Foundation in the United States, gaining international research experience. Upon returning to Japan, he served in various capacities, including at Keio University Hospital, as a lecturer at Saitama Medical University, and as an associate professor at Tokyo Dental College, accumulating extensive achievements in clinical practice, research, and education within the fields of internal medicine and rheumatology.
His expertise in autoimmune diseases, inflammation control, and integrated treatment of systemic diseases is a critically important area for the clinical application of regenerative medicine. This knowledge is positioned as a core element in the practice of 'Longevity Medicine,' which our association will promote in the future.
With this appointment, Tokyo Relife Clinic will proceed with building a more advanced and comprehensive medical care system that integrates cutting-edge regenerative medicine technologies, such as stem cell therapy, immune cell therapy, and exosome-related medicine, with internal medicine and immunological knowledge.
2. Profile
Chief Advisor for Regenerative Medicine, Tokyo Relife Clinic
Kensei Tsuzaka, M.D., Ph.D.

■ Career
1988 Graduated from Keio University School of Medicine
1993 Researcher at Oklahoma Medical Research Foundation, USA
1996 Worked at Keio University Hospital
2000 Lecturer at Saitama Medical University
2009 Completed graduate school at Keio University, obtained Ph.D.
2009 Associate Professor at Tokyo Dental College
2026 Chief Advisor for Regenerative Medicine at Tokyo Relife Clinic
■ Qualifications
Doctor of Medicine (M.D.)
Ph.D.
Certified Internal Medicine Specialist by The Japanese Society of Internal Medicine
Certified Rheumatology Specialist by The Japan College of Rheumatology
■ Professional Affiliations
The Japanese Society of Internal Medicine
The Japan College of Rheumatology
Member of American College of Rheumatology (ACR)
3. Comment from Chief Advisor Kensei Tsuzaka
I am deeply honored to join Tokyo Relife Clinic as Chief Advisor for Regenerative Medicine.
While I have been involved in clinical practice, research, and education in the field of internal medicine, primarily focusing on autoimmune diseases and inflammation control, the recent advancements in regenerative medicine are opening up new possibilities for diseases that were previously difficult to treat fundamentally.
Moving forward, I will leverage my accumulated immunological and internal medicine knowledge as a foundation, working towards the realization of comprehensive and individually optimized medical care through its integration with regenerative medicine.
Furthermore, I am committed to prioritizing the assurance of safety and efficacy based on scientific evidence, striving to provide truly valuable medical care to patients.
■ About Tokyo Relife General Incorporated Association
Tokyo Relife Clinic, operated by Tokyo Relife General Incorporated Association, is positioned as a core medical institution for implementing research findings into clinical practice. The clinic is equipped with a Cell Processing Center (CPC) designed according to advanced safety management standards, providing medical care that emphasizes quality, safety, and traceability in stem cell therapy, NK cell therapy, fibroblast therapy, and exosome-related medicine. Moreover, it achieves advanced longevity medicine that considers the quality of the medical experience through individually optimized treatment plans and an environment with high privacy.
Tokyo Relife Clinic
7-8-17 Ginza, Chuo-ku, Tokyo 104-0061, TORAYA Ginza Building 6–8F
TEL: 0120-660-329 (Reception hours: 10:00–19:00)
Official Website: https://www.tokyo-relife.com
Inquiry Form: https://tokyo-relife.com/contact
*Please select 'Other' in the form for inquiries.
FAQ
What are Dr. Kensei Tsuzaka's areas of specialization?
He specializes in internal medicine, rheumatology, autoimmune diseases, inflammation control, and integrated treatment of systemic diseases.
What is 'Longevity Medicine' promoted by Tokyo Relife Clinic?
It is healthcare aiming to extend healthy lifespans by integrating advanced regenerative medicine technologies with internal medicine and immunological knowledge to provide personalized, comprehensive treatment.
What treatments will be strengthened by Dr. Tsuzaka's appointment?
Regenerative medicine technologies such as stem cell therapy, immune cell therapy, and exosome-related medicine will be integrated with internal medicine and immunological knowledge to provide more advanced treatments.